Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in NEUROCRINE BIOSCIENCES INC
BNP PARIBAS FINANCIAL MARKETS holds 213,992 shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $30.4M as of 2025-Q4. The position was increased (++111.9% shares). NBIX represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$30.4M
Current Shares
213,992
Total Value Change
-$28.9M
Total Shares Change
-216,617
Other major holders of NBIX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 213,992 |
+111.9% |
| $30.4M |
| 0.0% |
| $140.95 |
46 |
| 2025-Q3 | Decreased | 100,975 | -11.6% | $14.2M | 0.0% | $140.27 | 0 |
| 2025-Q2 | Decreased | 114,185 | -51.9% | $14.4M | 0.0% | $125.42 | 0 |
| 2025-Q1 | Decreased | 237,215 | -18.2% | $26.2M | 0.0% | $113.16 | 0 |
| 2024-Q4 | Decreased | 289,840 | -45.6% | $39.6M | 0.0% | $137.06 | 0 |
| 2024-Q3 | Increased | 533,324 | +23.9% | $61.4M | 0.0% | $115.06 | 36 |
| 2024-Q2 | Decreased | 430,609 | -0.3% | $59.3M | 0.0% | $137.67 | 0 |